|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/497 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2013.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61K 31/496 | (2013.01) |
| (11) | Number of the document | 3372231 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16862109.2 |
| Date of filing the European patent application | 2016-11-02 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2016/082536 |
| Date | 2016-11-02 |
| (87) | Number | WO 2017/078049 |
| Date | 2017-05-11 |
| (30) | Number | Date | Country code |
| 2015217152 | 2015-11-04 | JP |
| (72) |
EGUCHI, Tomohiro , JP
YOSHIDA, Taku , JP
KADO, Ruriko , JP
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411,
JP
|
| (54) | PHARMACEUTICAL COMPOSITION FOR CANCER IMMUNOTHERAPY PURPOSES AND/OR IMMUNOSTIMULATION PURPOSES WHICH CONTAINS DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT |
| PHARMACEUTICAL COMPOSITION FOR CANCER IMMUNOTHERAPY PURPOSES AND/OR IMMUNOSTIMULATION PURPOSES WHICH CONTAINS DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT |